Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany

被引：20
|
作者：
Hoelzer, S
Steiner, D
Bauer, R
Reiners, C
Farahati, J
Hundahl, SA
Dudeck, J
机构：
[1] Univ Giessen, Inst Med Informat, D-35392 Giessen, Germany
[2] Univ Giessen, Clin Nucl Med, D-35392 Giessen, Germany
[3] Univ Wurzburg, Clin & Policlin Nucl Med, D-97070 Wurzburg, Germany
[4] Amer Coll Surg, Commiss Canc, Chicago, IL USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 2000年 / 27卷 / 10期
关键词：
differentiated thyroid cancer; guidelines; radioiodine; treatment;
D O I：
10.1007/s002590000333
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
This prospective, observational study of a cohort of thyroid cancer patients in Germany focusses on the "real-world" practice in the management of thyroid cancer patients. This report includes data from 2376 patients with primary differentiated thyroid carcinoma first diagnosed in the year 1996, The study reveals considerable differences in actual practice concerning surgery and radioiodine treatment. The results indicate that consensus is lacking with respect to the multimodality treatment approach for differentiated thyroid carcinoma. Our analysis represents the most current and comprehensive national assessment of presenting patient characteristics, diagnostic tests, treatment and complications for thyroid cancer.
引用
收藏
页码：1465 / 1472
页数：8
相关论文
共 50 条
  • [31] Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)
    Dietlein, M.
    Dressler, J.
    Eschner, W.
    Gruenwald, F.
    Lassmann, M.
    Leisner, B.
    Luster, M.
    Moser, E.
    Reiners, Chr.
    Schicha, H.
    Schober, O.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2007, 46 (05): : 213 - 219
  • [32] Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer
    Albano, Domenico
    Bertagna, Francesco
    Panarotto, Maria Beatrice
    Giubbini, Raffaele
    PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [33] Radioiodine therapy of metastatic lesions of differentiated thyroid cancer
    Luster, M.
    Haenscheid, H.
    Freudenberg, L. S.
    Verburg, F. A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (06) : 21 - 29
  • [34] Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients
    M. G. Castagna
    S. Cantara
    F. Pacini
    Journal of Endocrinological Investigation, 2016, 39 : 1087 - 1094
  • [35] The therapeutic management of differentiated thyroid cancer
    Sipos, Jennifer A.
    Mazzaferri, Ernest L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (15) : 2627 - 2637
  • [36] Radioiodine Imaging for Differentiated Thyroid Cancer: Not All Radioiodine Images Are Performed Equally
    Van Nostrand, Douglas
    THYROID, 2019, 29 (07) : 901 - 909
  • [37] Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients
    Castagna, M. G.
    Cantara, S.
    Pacini, F.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (10) : 1087 - 1094
  • [38] Small differentiated thyroid cancer: Time to reconsider clinical management and treatment
    Momesso, Denise Prado
    Vaisman, Fernanda
    Cordeiro de Noronha Pessoa, Cencita Hosanah
    Corbo, Rossana
    Vaisman, Mario
    SURGICAL ONCOLOGY-OXFORD, 2012, 21 (04): : 257 - 262
  • [39] Sorafenib in the treatment of radioiodine-refractory differentiated thyroid cancer: a meta-analysis
    Shen, Chen-Tian
    Qiu, Zhong-Ling
    Luo, Quan-Yong
    ENDOCRINE-RELATED CANCER, 2014, 21 (02) : 253 - 261
  • [40] Management of differentiated thyroid carcinoma with radioiodine and recombinant human TSH
    Sugino, Kimintori
    Ito, Koichi
    Takami, Hiroshi
    ENDOCRINE JOURNAL, 2006, 53 (06) : 723 - 728
12345